Soliris
Replacement
|
Medicines
|
22/08/2013
The marketing authorization holder informed its supplied customers in a letter dated August 22, 2013, that visible particles were detected in some vials and that a recall of the two affected batches will therefore be carried out.
| Name of the medicinal product | Soliris 300mg Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | EU/1/07/393/001 |
| Marketing authorisation holder | Alexion Europe SAS Zurückrufende Firma: Alexion Pharma Germany GmbH |
| Batch number(s) | 00010D, 00010DR |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0870 |
Further inquiry note
Page last modified:
12/07/2022